Recent Updates

Published: 
May 31, 2017
Chapter 16

This chapter focuses on preoperative autologous donation (PAD). There are other types of autologous blood use (e.g. acute normovolemic hemodilution and intraoperative and postoperative blood salvage) which are not discussed in this chapter.

PAD refers to the donation of blood by a patient for his/her own future use; generally this is for a scheduled elective surgery. The top three procedures associated with a request for a PAD are total hip replacement, total knee replacement and hysterectomy.

In most cases, allogeneic blood transfusions are a safe and available option. Autologous and directed donations should be confined to circumstances of rare blood types or plasma protein deficiencies in which  allogeneic units may not meet patient needs. Rare blood types represent only a small number of autologous units collected each year. See Chapter 13 of this Guide for more information on directed donations.

Transfusion
Published: 
Aug 4, 2017
Chapter 15

Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. Specialty blood products available to physicians include CMV-seronegative, irradiated, and washed red blood cells or platelets. This chapter describes the preparation of these blood components and the clinical setting in which they are of greatest benefit.

Transfusion
Published: 
Aug 2, 2017
Chapter 13

While the practice of transfusion of blood products to neonatal and pediatric recipients has much in common with the transfusion of blood products to adults, there are several important differences and special circumstances. This chapter highlights the most common considerations that are unique to this group of patients.

Transfusion

Upcoming Events

When
October 13, 2018 | 8:00AM to October 16, 2018 | 6:00PM
Where

Boston, MA

The AABB Annual Meeting is the premiere event for healthcare professionals in the fields of transfusion medicine and cellular therapies.

Click here for more information.

Transfusion
Stem Cells
When
November 16, 2018 | 8:00AM to November 17, 2018 | 6:00PM
Where

Edmonton

The purpose of the conference is to bring together multiple voices to support and build inclusive an equitable teaching and learning environments for medical staff, sickle cell disease patients, their families, first responders the public and other stakeholders. The event will be targeted towards physicians, surgeons, researchers and other medical practitioners within the community committed to finding a cure for Sickle Cell Anemia and more knowledge of the continued effects of sickle cell anemia trait.

Transfusion
Stem Cells
When
August 16, 2018 | 12:00PM to 7:00PM
Where

Vancouver

Join us at our upcoming CBR Research Day on Thursday, August 16th!  This is always a spectacular event, starting off with lunch and terrific 3 minute PPT presentations by our 25+ summer students.  This will be followed by a keynote address by Dr. Farah Alibay, an Aerospace Engineer at NASA’s Jet Propulsion Laboratory.  And finally, there will be loads of posters, with beer, wine, and a BBQ dinner for all to enjoy!

Transfusion
Organs and Tissues
Stem Cells

Blog

lifetime achievement award

Modified on: 
Jun 13, 2018

On June 5, Canadian Blood Services was honoured to accept the Canadian Operational Research Society's Omandt Solandt Award at a reception in Halifax, Nova Scotia. Michelle Rogerson, Director, Supply Chain (Atlantic), Canadian Blood Services, accepted the award on behalf of the organization.

blood on the move

Modified on: 
Jun 13, 2018

On the surface of our red blood cells are proteins called antigens. There are more than 600 known antigens — and some combinations of antigens are far less common than others.

Kidney graphic

Modified on: 
May 23, 2018

On May 5th, the Kidney Foundation of Canada announced that Dr. Peter Nickerson is the winner of their 2018 Medal for Research Excellence. A well deserved honour indeed. We're proud to congratulate Dr. Nickerson on this award.